Contract Services Clinical Research

InxMed's IN10018 Receives U.S. FDA Fast Track Designation

InxMed (Nanjing) Co., Ltd. ("InxMed" or "Company"), a clinical stage biotech company dedicated to developing innovative, individualized medicines with inte...

 August 16, 2021 | News

Clarivate Acquires Bioinfogate

Expanding and integrating drug toxicity data and translational safety intelligence from OFF-X into all aspects of the life science cycle, allowing customer...

 August 05, 2021 | News

$3.3 million to support Australians living with a rare disease

The Morrison Government is providing $3.3 million to support the approximate two million Australians living with a rare disease, providing them with suppor...

 August 02, 2021 | News

Curia to Acquire US-Based LakePharma

Adds integrated biologics development platform from discovery through GMP manufacturing Curia, formerly AMRI, a leading contract research, development and...

 July 19, 2021 | News

Atossa Therapeutics Receives Approval To Open Clinical Study of AT-H201 in Australia

Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of signi...

 July 08, 2021 | News

Toxicology IND Preclinical Research Services by Altogen Labs CRO

Pharmacology and toxicology testing performed both in vitro and in vivo, ensuring safety and effectiveness that is of utmost importance for any novel medic...

 July 06, 2021 | News

I-Mab Announces Multiple Advancements of 4-1BB Bispecific Antibody Portfolio

First patient dosed in U.S. phase 1 clinical trial of TJ-CD4B/ABL111 in patients with advanced or metastatic solid tumors China sites to join the d...

 July 02, 2021 | News

Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs

Key Points GBM AGILE pivotal study of paxalisib is recruiting ahead of expectations, with almost 25 sites now open to the paxalisib arm. Paxalisib phas...

 July 01, 2021 | News

Phase III Clinical Trial of BIOKANGTAI COVID-19 Vaccine Initiated in Malaysia

On June 21, local time, phase III clinical fieldwork of the Inactivated COVID-19 Vaccine (Vero cells) independently developed and manufactured by Shen...

 June 23, 2021 | News

BIO to Hold First-Ever Clinical Trial Diversity Summit

The Biotechnology Innovation Organization (BIO) will hold its first-ever BIO Clinical Trial Diversity Summit June 24-25, 2021 to focus on th...

 June 22, 2021 | News

Medidata to Offer Secure Platform for Decentralization of Clinical Trials

  The first company in the world to unify direct patient data capture technology with study oversight and monitoring, Medidata redefines end-to-end...

 June 16, 2021 | News

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy

93% efficacy against predominantly circulating Variants of Concern and Variants of Interest 91% efficacy in high-risk populations 100% efficacy against...

 June 15, 2021 | News

Novavax Announces Positive Data for COVID-19 Beta (B.1.351) Variant Strain Vaccine

Novavax Announces Positive Data from Three Complementary Studies of COVID-19 Beta (B.1.351) Variant Strain Vaccine - Primates boosted with rS-B.1.351 vacc...

 June 12, 2021 | News

OCT Clinical among the top 3 CROs in 2020

In 2020 OCT Clinical initiated projects for various pharmaceutical companies from Asia (Handok Inc.), and Europe (Stayble Therapeutics), and for several so...

 June 11, 2021 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close